title: Identification of Tau Toxicity Modifiers in the Drosophila Eye.
abstract: Drosophila is a powerful model to study human diseases thanks to its genetic tools and ease of screening. Human genes can be expressed in targeted organs and their toxicity assessed on easily scorable external phenotypes that can be used as readout to perform genetic screen of toxicity modifiers. In this chapter, I describe how to express human Tau protein in the Drosophila eye, assess protein expression by western blot, assess Tau toxicity by quantifying the size of the Tau-induced rough eye, and perform a genetic screen of modifiers of Tau toxicity in the Drosophila eye.
authors.affiliation: Institut Pasteur de Lille, INSERM, UMR1167, Université de Lille, 1 rue du Prof. Calmette, 59019, Lille, France. pierre.dourlen@pasteur-lille.fr.
authors.forename: Pierre
authors.initials: P
authors.lastname: Dourlen
mesh_terms: D000818:Animals; D030801:Animals, Genetically Modified; D015153:Blotting, Western; D004195:Disease Models, Animal; D004330:Drosophila; D029721:Drosophila Proteins / Q000235:genetics / Q000378:metabolism* / Q000633:toxicity; D005123:Eye / Q000378:metabolism* / Q000473:pathology; D005260:Female; D006801:Humans; D008297:Male; D009410:Nerve Degeneration / Q000378:metabolism / Q000473:pathology; D016875:tau Proteins / Q000235:genetics / Q000378:metabolism* / Q000633:toxicity
chemical_list: D029721:Drosophila Proteins; D016875:tau Proteins
keywords: Alzheimer; Drosophila; Eye; Modifier screen; Neurodegeneration; Neuron; Tau